Stock analysts have recommended Overweight for Godrej Consumer, Buy for Campus Activewear, and Neutral for Amara Raja. They suggest Outperform for both Delhivery and Indus Towers, implying these stocks could potentially outperform their respective market averages. The ratings reflect the current market trends and are a guide for investors' decisions.

Marksans Pharma has announced their Q4 and full year financial results for 2025-26, with an unmodified auditor's opinion signaling a clean bill of health. The company's board proposed a final dividend of Rs. 0.90 per share, pending approval at the upcoming Annual General Meeting.

HCLTech and Pegasystems have strengthened their partnership to leverage AI for modernizing legacy systems. This collaboration aims to replace aging systems, streamline workflows, and facilitate secure, scalable, and robust enterprise modernization using HCLTech's AI Force and Pega Blueprint.

Paint companies in India, including Grasim, Berger, and Indigo, are grappling with potential demand issues due to recent price increases caused by inflation and crude-linked costs. The firms anticipate testing the limits of demand elasticity (Grasim), and both Indigo and Berger warn about increased competitive pressure and margin squeeze.

Marksans Pharma has reported a significant 21% year-on-year increase in its Q4 revenue, reaching ₹8.6 billion, indicating robust growth in their business operations.

Sun Pharma reports a 3% year-over-year increase in EBITDA, anticipating high single-digit revenue growth for the fiscal year 2027, with R&D expenses accounting for 6-7% of sales. LG India has achieved an 8% year-over-year revenue growth and aims for mid-teen growth in fiscal year 2027, along with a target of double-digit EBITDA margin.

HDFC Life experiences the least growth in all areas during Q4 and the financial year 2025-26. Similarly, ICICI Prudential Life demonstrates sluggish growth in both quarters.

FMCG companies like Hindustan Unilever, Britannia, and Dabur are considering raising prices and reducing product sizes (shrinkflation) due to anticipated slower volume growth in FY27 as a result of inflation and escalating input costs. These measures aim to safeguard their profit margins.

CONCOR's open interest increased by 10.4%, suggesting changes in market positions within the transport services sector. The mixed trends in price, trading volumes, and moving averages indicate varying sentiments among investors towards this industry.

Torrent Pharma aims to generate approximately INR 450 crore in synergies from their acquisition of JB Pharma within three years, with potential savings of up to 80% by the second year and ongoing benefits in the third year.

The Central Bank of India, now exempt from PCA (Prompt Corrective Action), is aiming to diversify into wealth management services to enhance its profits by catering to premium clientele.

Prostarm Info Systems reported impressive Q4 and full-year results for FY26, showcasing a steady growth trajectory. The company's profit after tax saw a remarkable compound annual growth rate of 19.6% over the past three years, accompanied by a return on capital employed (ROCE) of 16.5%. Moreover, their return on equity stood at 11.5%, while revenue experienced a robust 18.8% compound annual growth rate during the same period.

Jefferies continues to recommend buying NTPC shares, predicting a price of ₹470. This optimism is based on anticipated profit growth in FY26 due to the addition of 8.1 GW capacity. The brokerage also revised their FY27-28 earnings per share estimates, highlighting that the ramp-up of new capacity could serve as a significant catalyst for stock appreciation, even though there's a slight reduction in anticipated capacity additions for FY28.

Despite reporting lackluster Q4 results, GAIL shares surged by approximately 5% today, indicating that investor confidence in the company remains robust.

Despite fluctuating raw material costs, Gujarat State Fertilizers remains optimistic about its growth due to strategic pricing adjustments, effective inventory management, and a positive fertilizer market demand forecast.

HeidelbergCement India reported a 5.6% year-on-year increase in Q4 revenues, reaching ₹646 crores, marking a rise from ₹612 crores in the same period last year.

Seven companies, including Abbott India, Torrent Pharma, and Sun Pharma, have announced their dividend record dates. This means shareholders of these companies will receive their dividends soon, as stated in the companies' respective announcements.

Bajaj Holdings experiences an increase in trading volume by 13.99%, suggesting a notable interest among investors. The stock has climbed 1.16%, reflecting a mixed response from both technical and fundamental indicators, shaping overall investor sentiment.

Anupam Rasayan India has proposed purchasing a 26% share in Bliss GVS Pharma for approximately INR 829 crores, following an earlier deal for a 43.3% stake. This move, which values each share at INR 299, is subject to SEBI's Substantial Acquisition of Shares and Takeovers (SAST) regulations.

MTNL faces a bond payment issue on June 1, 2026, as they couldn't fund the 7th semi-annual interest for Bond Series VIIB due to insufficient funds in their Escrow account. However, it's noteworthy that these bonds carry a sovereign guarantee, offering some level of assurance to investors.

The BSE 100 undergoes changes with the addition of Paytm, Ashok Leyland, and CG Power, while Ambuja, Tube Investments, and Colgate-Palmolive are now no longer part of this index.

Concord Enviro Systems experienced a 6% drop in Q4 revenue for FY26, primarily due to ongoing supply chain challenges. However, the company is working on bolstering its workforce, venturing into the solar sector, and maintaining its position as a key player in the core industry.

Shilpa Medicare significantly boosted its Q4 net profit by approximately 700% year-on-year, reaching ₹108 crore, with revenue increasing 32% to ₹437 crore. Additionally, EBITDA rose 49.6% and maintained a margin of 27.4%.

RBL Bank aims to buy a 26% stake worth approximately INR 11,735 crores through an open offer. This move signifies the bank's expansion plans and commitment to growth.

Shilpa Medicare secures approval from the CDSCO for its albumin Phase 3 trial, a significant step forward. The company plans to submit an application to the European Medicines Agency (EMA) during the first half of fiscal year 2027.

RCF announces Q4 results for FY26, reporting a revenue of ₹18,480 crores and PAT of ₹429.8 crores. The company recommends a dividend of ₹1.34 per share, representing a yield of 13.4%. Additionally, subsidy claims have been disclosed in the report.

Today, Sun Pharma, Hindalco, Eicher Motors, Torrent Pharma, and NTPC Green are set to release their Q4 results, with ITC, LIC, GAIL, Emami, Max Health, JSW Cement, Va Tech, and 3M India also under the spotlight for their financial performances. Investors will closely monitor these companies' results to gauge their performance in the recent quarter.

J.G. Chemicals surpassed its FY26 revenue record with a substantial ₹972.9 crore, accompanied by strong EBITDA (₹97.9 crore) and PAT (₹68.6 crore). Notably, Q4 showed a 27.6% year-over-year increase in revenue to reach ₹286.2 crore. The company is emphasizing its Gujarat project, expansions, and export initiatives for future growth.

The Sensex experienced a decline of 135 points with the Nifty remaining unchanged, as Bajaj Finance, HUL, and Tech Mahindra led the list of top losers. However, Apollo Hospitals and Honeywell Automation showed growth, while oil stocks climbed due to a drop in Brent crude below $105/barrel.

In the financial year 2026, private banks encountered a decline in their return on equity due to compressed net interest margins and losses from treasury operations. Notable banks like ICICI Bank, Axis Bank, HDFC Bank, and Kotak Mahindra experienced profitability hurdles as a result.

Le Travenues experienced a 24% drop in Q4 EBITDA, with profits decreasing from ₹248M to ₹200M year-on-year. The margin also shrank significantly, falling from 8.73% to 6.5%.

LG India's Q4 revenue increased by 8.1%, reaching ₹80.54 billion, with an EBITDA margin of 11.7%. For the full year FY26, their total revenue grew by 1% to ₹246.05 billion and they entered into long-term solar power agreements for sustainable energy usage.

MTAR Tech's co-founder recently disposed of 60,000 shares in the open market, transacting between May 19th and 20th, 2026. This move may signal changes within the company or personal financial decisions by the co-promoter.

SPML Infra has secured a significant ₹165 crore deal, bolstering their short-term workload visibility. This new contract fortifies the company's immediate execution plans.

Key Shares to Monitor on May 22: LIC, ITC, Max Healthcare, Nykaa, and Tata Steel are worth keeping an eye on today.

The Nifty index is leaning heavily on Reliance Industries for support during a crucial period, as the conglomerate plays a significant role in determining its direction.

Automotive Axles reported a significant QoQ profit increase of 17.3% for Q4 FY26, with revenue also climbing by 18.1%. However, the stock faced some uncertainty due to margin concerns, yet still managed to climb 4.9% on May 20, 2026, reaching a high of ₹1,781.65.

PUMA Securities has offloaded approximately 216,000 shares of Dredging Corporation at an average price of INR 1,113.5 each in recent trading activities on the National Stock Exchange.

Igarashi Motors India has announced a dividend of INR 1.30 per share for the financial year 2026. Additionally, the company has appointed Sharp & Tannan as internal auditors and BY Associates as cost auditors moving forward, according to BSE.

Mankind Pharma has set its sights on moderate, teen-digit expansion rates, marking a transition to a more stable, maturing phase compared to its previous high growth of 50-60%. This shift reflects normalization within the business.